AZ and GSK Dip Into Diagnostics To Support COVID-19 UK Tests
Also Lending Expertise In Automation And Robotics
Executive Summary
The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.
You may also be interested in...
GSK Vaccine Sales Hit By COVID-19 But Initial Signs Of Recovery
GlaxoSmithKline sees initial signs of recovery from the coronavirus pandemic in terms of vaccination rates and highlights its growing research progress against COVID, RSV and meningitis, although a UK expert warns against over-optimism.
Vir Advances HBV, Flu Programs While Focused On COVID-19
Vir began pursuing immunological approaches to infectious diseases three years before its COVID-19 work. Its hepatitis B, flu and HIV clinical trials are delayed about six months due to coronavirus-related issues.
Sanofi To Collaborate On Smartphone Tech For COVID-19 Self-Testing
Big pharma’s consumer division launches partnership with tech company Luminostics.